9,10-dimethyl-1,2-benzanthracene has been researched along with Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friesen, HG; Kelly, K; Monasterski, LG; Petkau, A | 1 |
Bland, KI; Bryant, MS; Ellis, LM; Hogancamp, WE; Sitren, HS; Souba, WW; Wittliff, JL | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Ischemia
Article | Year |
---|---|
Modification of superoxide dismutase in rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Ischemia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Neoplasm Proteins; Oxygen; Rats; Superoxide Dismutase | 1977 |
Lability of steroid hormone receptors following devascularization of breast tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Half-Life; In Vitro Techniques; Ischemia; Mammary Neoplasms, Experimental; Rats; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Time Factors; Tissue Preservation | 1989 |